BBI acquires exclusive global licence for MERS and SARS vaccines
21 October 2015 | By Victoria White
BBI has acquired an exclusive global license for the clinical development and commercialisation of the vaccines...
List view / Grid view
News
Domainex and ICL team up to discover myocardial infarction therapies
20 October 2015 | By Victoria White
Domainex has been selected as Imperial’s strategic drug discovery partner to provide services including biochemical and biophysical assay development...
HIFalpha gene could hold key to treating Parkinson’s disease
20 October 2015 | By Victoria White
Researchers found that when HIFalpha was ‘switched off’, nerve function in flies with Parkinson’s disease was restored...
Scripps scientists make leukaemia cells kill each other
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
Positive results for DelMar’s VAL-083 in ovarian cancer
19 October 2015 | By Victoria White
Preclinical data demonstrate the effectiveness of VAL-083 against cisplatin-resistant ovarian cancers...
Investigational New Drug Application filed for MERS vaccine
19 October 2015 | By Victoria White
Earlier this year, Inovio’s MERS vaccine induced 100% protection from a live virus challenge in a preclinical study...
Data on pGlu-3 Abeta antibody presented at Neuroscience 2015
19 October 2015 | By Victoria White
Pyroglutamate-3 Abeta (pGlu-3 Abeta), a post-translational modified Abeta, is a highly toxic Abeta variant which is abundant in brains of patients with Alzheimer’s disease...
New project aims to establish genome sequencing as a clinical tool
19 October 2015 | By Victoria White
Genomics has entered into a collaboration agreement in a research project focused on the translation of whole genome sequencing into clinical practice...
Nuevolution in drug discovery collaboration with Janssen
19 October 2015 | By Victoria White
Within the framework of the collaboration, Nuevolution will apply its drug discovery platform Chemetics to discover and advance drug candidates...
Inflammation in the brain linked to risk of schizophrenia
16 October 2015 | By Victoria White
The research raises the possibility that testing of those most at risk of the disorder could allow them to be treated early enough to avoid the disorder's most severe symptoms...
York scientists one step closer to finding a new generation of antibiotics
16 October 2015 | By Victoria White
The scientists used novel genetic engineering tools to manipulate the genes required for antibiotic biosynthesis...
Researchers describe new molecular markers for high-risk neuroblastoma
16 October 2015 | By Victoria White
Researchers have identified previously unknown genomic alterations leading to up-regulation of the telomerase reverse transcriptase gene (TERT). Overexpression of TERT is often associated with cancers and tumour formation...
Breast cancer vaccine OQR200 completes proof-of-concept study
15 October 2015 | By Victoria White
In the study, the vaccine elicited the expression of very high levels of polyclonal antibodies targeting multiple epitopes on Her2/neu...
Ablynx’s nanobody construct achieves proof-of-concept in tumour model
15 October 2015 | By Victoria White
The nanobody construct binds to two different immune modulators, proteins believed to be targets for the development of important cancer immunotherapies...
OICR, Novera and Janssen to develop haematological cancer therapies
15 October 2015 | By Victoria White
As part of the collaboration, Novera will discover and develop novel therapeutic compounds identified through OICR's drug discovery programme...
